Press Releases
Feb. 9, 2026
Synfini Introduces Integrated Microscale Purification, Delivering Assay-Ready Compounds in Hours Instead of Days
Indeterminate
GlobeNewswire, Inc.
Feb. 9, 2026
Arch Biopartners Scientists Publish New Data Linking the Cytokine IL-32 to Inflammation and Diabetic Kidney Disease
Indeterminate
GlobeNewswire, Inc.
Feb. 9, 2026
SparingVision Successfully Completes PRODYGY Trial Patient Dosing with SPVN06, its Novel Neuroprotective Gene Therapy
Indeterminate
GlobeNewswire, Inc.
Feb. 9, 2026
Just Days Before Valentine’s Day, Award-Winning Author Reframes the Holiday as a Living Legend
Neutral
EIN Presswire
Feb. 3, 2026
Author Michael Strode Joins Ruadán Books with Speculative Historical Thriller
Neutral
EIN Presswire
Feb. 2, 2026
Ready-to-Drink (RTD) Tea Market Valued at US$ 42.4 Bn in 2026 Driven by Health Trends
Neutral
EIN Presswire
Feb. 5, 2026
Amazon Bestselling Author E. Masson Launches Breathtaking New Romance 'Selecting The Wrong Love'
Neutral
EIN Presswire
Feb. 5, 2026
New Zealand Author Wins 2026 Independent Press Award for Visionary Fiction
Neutral
EIN Presswire
Feb. 5, 2026
Award-Winning Fantasy Novel 'Orphan's Quest' Wins Global Book Awards 2025
Neutral
EIN Presswire
Feb. 5, 2026
The Hip Hop Museum Highlights Black History Month Book Series and 1 Dollar 1 Mic 1 Movement Campaign
Neutral
EIN Presswire
Feb. 5, 2026
FibroBiologics Announces Issuance of Canadian Patent Covering Novel Fibroblast-Based Treatment for Cachexia
Indeterminate
GlobeNewswire, Inc.
14 hours ago
Two years, one insight: How lens design changes shape myopia control
Neutral
EIN Presswire
Feb. 4, 2026
Biodexa Announces Exclusive License of Otsuka’s OPB-171775, a potent Phase 1 ready Molecular Glue for GIST
Indeterminate
GlobeNewswire, Inc.